NewslettersCell Therapy NewsA Pilot Clinical Trial of Cell Therapy in Heart Failure with Preserved Ejection FractionBy Danielle Corrigan - July 4, 20220179Scientists investigated the effects of CD34+ cell therapy in patients with heart failure with preserved ejection fraction.[European Journal of Heart Failure]Abstract